PMC:7597510 / 1127-1254
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7597510","sourcedb":"PMC","sourceid":"7597510","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7597510","text":" events such as infection and vaccination. Approximately 40%–70% of GBS cases develop following infection, and autoantibodies a","tracks":[{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T21","span":{"begin":16,"end":25},"obj":"Disease"},{"id":"T22","span":{"begin":68,"end":71},"obj":"Disease"},{"id":"T23","span":{"begin":96,"end":105},"obj":"Disease"}],"attributes":[{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"subj":"T21","pred":"source","obj":"LitCovid-PD-MONDO"},{"subj":"T22","pred":"source","obj":"LitCovid-PD-MONDO"},{"subj":"T23","pred":"source","obj":"LitCovid-PD-MONDO"}]},{"project":"LitCovid-PubTator","denotations":[{"id":"50","span":{"begin":16,"end":25},"obj":"Disease"},{"id":"51","span":{"begin":96,"end":105},"obj":"Disease"}],"attributes":[{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"MESH:D007239"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"MESH:D007239"},{"subj":"50","pred":"source","obj":"LitCovid-PubTator"},{"subj":"51","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-MONDO","color":"#ecd893","default":true},{"id":"LitCovid-PubTator","color":"#be93ec"}]}]}}